St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
- Fundraising
St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
- Fundraising
Alex Generous, PhD
Scientific Writer
Alex Generous, PhD, is a Scientific Writer in the Strategic Communications, Education and Outreach Department at St. Jude.
Stories by Alex Generous
Shortening the gap between pediatric and adult care improves sickle cell outcomes
Closing the time gap between pediatric and adult care could have significant benefits for patients.
Global peer community sets standards to save vulnerable children from infectious diseases
St. Jude is helping train and make guidelines to prevent and treat infections during pediatric cancer treatment worldwide.
Boot camp trains sickle cell disease ‘pain crises champions’ to improve patient care
St. Jude and UTHSC are training nurses worldwide how to better care for people with sickle cell disease.
Long-acting injectable HIV drugs safe for treating adolescents
Learn how long-lasting drugs offer hope for adolescent with HIV.
Influenza virus provides first evidence of bats’ potential as an intermediate host
Explore research showing bats may be an intermediate influenza host.
Preventing sepsis during treatment for pediatric cancer might prevent neurocognitive problems decades later in survivors
Childhood sepsis during cancer treatment appears to have a lasting impact on only one organ.
Expanding access to genetic research and care
St. Jude is leading more inclusive genetic studies and translating them to better care.
St. Jude investigator led multi-center effort to define Diamond Blackfan anemia syndromes’ guidelines
Explore the newly published guidelines for Diamond Blackfan anemia syndromes.
St. Jude ProteinPaint adopted by the National Cancer Institute for cancer data visualization
Discover why the National Cancer Institute built St. Jude ProteinPaint into their national database.
St. Jude takes the lead on prevention and treatment of COVID-19 in vulnerable kids
A St. Jude retrospective study reveals why pediatric cancer treatment should continue during COVID cases.